CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc.:
Launched EVOMELA® (melphalan for injection, multiple myeloma) in August '19, only melphalan commercially available in China: $4.2 m Q3 20 revenues/guiding FY 2020 $14 m revenue. Partnership w BioInvent: acq'd Greater China comm/dev rights to anti-FcyRIIB mAb w potential applications across multiple tumor types in 1L & refractory settings. Co-commercial asset CNCT-19/CD19 CAR-T (partnered w/ Juventas): ongoing Ph 1 trials in B-NHL and B-ALL, exp to initiate registration trials by YE 2020. Exp to initiate Ph 1 study for CID-103 (anti-CD38 mAb) in EU in Q1 2021. Strategic BD approach enables opportunistic pipeline expansion.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Asia, US - South Atlantic
Disease Space
Oncology
Listing
Public, USA
Market Cap
100MM - 500MM
Website:
Profiles:
Address:
9620 Medical Center Drive
Suite 300
Rockville, MD 20850
United States
Suite 300
Rockville, MD 20850
United States
More info:
My account:
Company Participants at Solebury Trout Corporate Access 1x1 Calls - Week of April 13
- Wei-Wu He, PhD, CEO & Chairman
Top 10 Holders of CASI Pharmaceuticals Inc
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| IDG-Accel China Growth Fund III Associates LP | 7.90 | 7,973,536 | 14.99 | 13F | 12/31/20 |
| Consonance Capital Management LP | 7.51 | 7,576,431 | 14.24 | 13F | 12/31/20 |
| Federated Global Investment Management Corp. | 6.94 | 7,000,000 | 13.16 | 13F | 12/31/20 |
| The Vanguard Group, Inc. | 3.84 | 3,877,966 | 7.29 | Funds | 2/28/21 |
| Vanguard Group, Inc. (Subfiler) | 3.15 | 3,175,917 | 5.97 | 13F | 12/31/20 |
| BlackRock Fund Advisors | 2.08 | 2,094,473 | 3.94 | 13F | 12/31/20 |
| Wellington Shields Capital Management LLC | 2.05 | 2,071,765 | 3.89 | 13F | 12/31/20 |
| Wellington Shields & Co. LLC | 1.80 | 1,812,769 | 3.41 | 13F | 12/31/20 |
| BlackRock Institutional Trust Co. NA | 1.34 | 1,350,525 | 2.54 | 13F | 12/31/20 |
| Ikarian Capital LLC | 1.26 | 1,268,154 | 2.38 | 13F | 12/31/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.